No products in the cart.
TYR: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TYR. The page also collects GeneMedi’s different modalities and formats products for TYR in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TYR target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Introcelluar Protein.
The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3′ half of this gene. [provided by RefSeq, Oct 2008]
|
Target ID |
GM-IP0016
|
|
Target Name |
TYR
|
|
Gene ID |
7299
|
|
Gene Official Name |
TYR
|
|
Gene Alias |
ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3
|
|
Protein Sub-location |
Introcelluar Protein
|
|
Category |
Therapeutics Target, Immuno-oncology Target
|
Pre-made anti-TYR monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research.
Pre-made anti-TYR monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TYR mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Filters
Sort results
Reset
Apply
Cat No. | Antibody Name | Format | Classified by tag | Order
|
|---|---|---|---|---|
Anti-TYR monoclonal antibody |
mab |
Therapeutics Target antibody |
